| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q2 2013 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TELA BIO INC | 11 | Q2 2024 | 7.6% |
| ADMA BIOLOGICS INC | 10 | Q1 2024 | 13.7% |
| OPTINOSE INC | 10 | Q2 2024 | 7.9% |
| REZOLUTE INC | 10 | Q2 2024 | 2.0% |
| ALIMERA SCIENCES INC | 9 | Q2 2024 | 43.3% |
| LANTHEUS HLDGS INC | 9 | Q4 2023 | 18.0% |
| JASPER THERAPEUTICS INC | 9 | Q4 2023 | 17.8% |
| HERON THERAPEUTICS INC | 7 | Q2 2024 | 14.0% |
| IMMUNOCORE HLDGS PLC | 6 | Q1 2023 | 13.7% |
| QUIPT HOME MEDICAL CORP | 6 | Q3 2023 | 4.8% |
View Velan Capital Investment Management LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-09-16 |
| SC 13D/A | 2024-09-16 |
| N-PX | 2024-08-29 |
| 13F-HR | 2024-08-14 |
| SC 13D/A | 2024-05-16 |
| 13F-HR | 2024-05-14 |
| SC 13G | 2024-03-28 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-09 |
| SC 13D/A | 2024-02-09 |
View Velan Capital Investment Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.